Skip to main content
OpenTrials
Completed

NCT Number: NCT03016936

MET: REevaluation for Perioperative cArdIac Risk (MET-REPAIR)

Multicentre international prospective cohort study designed to answer the question: "In patients undergoing elevated risk noncardiac surgery, are METs estimated by questionnaire associated with perioperative major adverse cardiovascular events or cardiovascular mortality?" If so:

1. What is the optimal cut-off for METs estimated by questionnaire to predict perioperative major adverse cardiovascular events or cardiovascular mortality? 2. How does the optimal cut-off compare with the currently guideline-endorsed 4-MET cut-off?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

45 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Universitätsklinikum Düsseldorf

Düsseldorf, Germany

About this study

In spite of scarce and non-conclusive evidence on the prognostic value of self-reported functional capacity for perioperative cardiovascular events, the estimation of cardiovascular functional capacity in metabolic equivalents (METs) based on a questionnaire represent the core question in the preoperative cardiac risk assessment in patients undergoing elevated risk noncardiac surgery endorsed by ESA, the ESC, and the ACC/AHA. MET-REPAIR will examine the ability of MET estimated using a questionnaire to predict perioperative cardiovascular events correcting for preoperative risk factors, (e.g. comorbidity and type of surgery) and calculate the effect on risk stratification (net reclassification improvement) by the addition of METs estimated by questionnaire to established risk scores, such as the Revised Cardiac Risk Score (Lee-index) and the NSQIP MICA . Further, investigators will address alternative approaches to functional capacity estimation (1. ability to climb stairs; 2. self-assessed functional capacity compared to peers; 3. Daily/weekly physical activity) and their predictive value for perioperative cardiovascular events.

The association between elevated natriuretic peptides prior to noncardiac surgery and perioperative cardiovascular events is well established. However, a direct comparison of the predictive ability of biomarkers vs. self-reported MET is lacking. Therefore, in a substudy (NTproBNP substudy), investigators will evaluate in how far the addition of NTproBNP improve prediction of perioperative cardiovascular events and cardiovascular mortality when added to clinical data and estimated METs.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Planned as Inpatients after surgery
  • 45 years of age or older AND undergoing elective elevated-risk noncardiac surgery as defined by either a Revised Cardiac Risk Index ≥ 2 [9] OR NSQIP MICA>1% [10]
  • 65 years of age or older and undergoing intermediate or high-risk procedures [3]
  • Signed Written informed consent

Exclusion criteria

  • Non-elective surgery, i.e. planned to occur ≤ 72 hours after diagnosis of the acute condition that makes the procedure necessary
  • Acute coronary syndrome or uncontrolled congestive heart failure within the last 30 days of planned day of surgery
  • Stroke within the last 7 days of planned day of surgery
  • Outpatients
  • Patients unable to perform ambulation due to congenital or longstanding illnesses/states (e.g. paraplegics, polio, etc; but explicitly not patients with fractures, needing hip replacement, etc.)
  • Unable to consent or unwilling to participate
  • Previous enrolment in MET REPAIR (in case of repeated surgery)

Treatment and study plan

Primary outcomes

  1. Composite of intra or postoperative inhospital cardiovascular mortality, nonfatal cardiac arrest, acute myocardial infarction, stroke and congestive heart failure requiring transfer to a higher care unit or prolonging stay on ICU/intermediate care (≥24h)

    Time frame: within 24 hours after surgery

    Composite of intra- or postoperative inhospital cardiovascular mortality, nonfatal cardiac arrest, acute myocardial infarction, stroke, and congestive heart failure requiring transfer to a higher unit of care or prolonging stay on ICU/intermediate care (≥24h).

Secondary outcomes

  1. composite of intra- or postoperative inhospital cardiovascular mortality, nonfatal cardiac arrest, acute myocardial infarction, stroke, and congestive heart failure requiring transfer to a higher unit of care or prolonging stay on ICU/IMC (≥24h)

    Time frame: at 30days after surgery or on discharge

    composite of intra- or postoperative inhospital cardiovascular mortality, nonfatal cardiac arrest, acute myocardial infarction, stroke, and congestive heart failure requiring transfer to a higher unit of care or prolonging stay on ICU/intermediate care (≥24h)

  2. Inhospital all-cause mortality

    Time frame: at 30days after surgery

  3. complications ≥ 3 in Clavien Dindo Classification

    Time frame: From date of surgery until up to day 30 after surgery or until discharge if occurred before day 30 and no follow-up call is carried out.

  4. length of In hospital stay (days), length of ICU stay (days in the ICU)

    Time frame: from date of surgery until discharge or until day 30 after surgery, whichever occurs first. .

  5. myocardial injury after noncardiac surgery (MINS)

    Time frame: From date of surgery until up to day 30 after surgery or until discharge if occurred before day 30 and no follow-up call is carried out.

    Only applicable for patients from centres routinely implementing a perioperative troponin screening

Sponsors and collaborators

Lead sponsor

European Society of Anaesthesiology

Other

Registry information

Official study title

MET: REevaluation for Perioperative cArdIac Risk (MET-REPAIR) Observational Multicentre Study

Acronym: MET-REPAIR

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Jan 11, 2017
Registry last updated
Feb 16, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.